Stanford University
Showing 101-150 of 1,688 Results
-
Sunita Rajdev
Senior Director for Licensing and Strategic Alliances, Office of Technology Licensing (OTL)
BioSunita Rajdev is the senior director of licensing and strategic alliances, life sciences, at the Stanford Office of Technology Licensing (OTL). She has over twenty years of experience in university technology transfer with expertise in intellectual property management, leading the negotiation of licensing and research collaboration agreements, business development, and startup formation. Sunita also extensively collaborates with other Stanford translation-focused groups to help create and manage strategic alliances with non-profit and for-profit entities to translate innovations from Stanford labs into products and services for public benefit.
Before joining the OTL in December 2019, Sunita held various technology transfer positions at UCSF, including time as its interim executive director, with multiple responsibilities in addition to licensing that included supporting the creation and management of large research collaborations.
Sunita received her Ph.D. in Pharmacology from the University of Pittsburgh and completed her postdoctoral training at UCSF. -
Nitya Rajeshuni
Clinical Instructor, Pediatrics - Critical Care
BioDr. Rajeshuni is a Clinical Instructor in the Department of Pediatrics at Stanford University. She is faculty with the Stanford Center for Asian Health Research and Education (CARE), the Center for Innovation in Global Health (CIGH), and the Maternal Child Health Research Institute (MCHRI). Dr. Rajeshuni earned her BS, MS in Epidemiology and Clinical Research, and MD from Stanford University. She completed residency training at the University of Pennsylvania and a Biodesign innovation fellowship at Harvard University.
Her research centers on advancing health equity among racial and ethnic minorities, with a particular focus on Asian populations. She investigates health disparities, access to care, and the implementation and evaluation of public and digital health solutions in the U.S. and low- and middle-income countries. Current projects include studying the impacts of maternal education and intimate partner violence on child outcomes. Her broader interests encompass promoting resilience and well-being in vulnerable communities worldwide and leveraging digital health to reduce health disparities. She is a recipient of a career development award through the CHIME Health Equity Scholars program funded by PCORI and will be studying the effects of social supports on resilience in pregnant people of minority descent. Her global collaborations include work with NGO Arogya World on diabetes prevention in India as a collaborator and member of the Board. She is also the Director of South Asia Outreach at Stanford CARE. She also serves as a Product Advisor to healthcare startup Yuimedi.
Dr. Rajeshuni is deeply committed to teaching and mentorship. At Stanford, she serves as Associate Program Director for CARE Scholars and the Team Science Fellowship, year-long data science programs that provide emerging researchers with structured mentorship, advanced analytical skills, and interdisciplinary collaboration to drive health equity research. She is Faculty Co-Director of FAMMED 210: The Healer’s Art, an international program offering a reflective, experiential course designed to nurture compassion, resilience, and the humanistic values essential to medicine. She mentors graduate, undergraduate, and high school students at Stanford and beyond, and serves as Faculty Advisor in the Department of Human Biology.
Outside academia, Dr. Rajeshuni is an accomplished vocalist, performing professionally with world music ensembles Wobbly World and San Francisco’s Peña Pachamama Carnaval Arts Program. -
Sachin Rajpal, MD
Clinical Instructor, Ophthalmology
BioDr. Sachin Rajpal is an ophthalmologist at Stanford Health Care. He is also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Rajpal specializes in cataract surgery and minimally invasive glaucoma surgery (MIGS). He also focuses on the medical and surgical management of pterygium (growths on the white of the eye) and ocular (eye) surface disease. His approach emphasizes comprehensive, patient-centered care, combining clinical excellence with clear communication and individualized treatment planning. He is particularly passionate about improving access to surgical care and enhancing the patient experience through the thoughtful application of emerging technology.
His research interests include patient adoption of digital diagnostic tools, technology-driven vision testing, and the development and regulation of leading-edge ophthalmic devices. He is also part of the Stanford Medicine Byers Eye Institute team working on a whole-eye transplant project focusing on vision restoration. Dr. Rajpal is actively involved in translational research that bridges clinical needs with scalable solutions.
Dr. Rajpal’s work has been presented at major conferences, including the Association for Research in Vision and Ophthalmology, American Society of Refractive and Cataract Surgery, and American Academy of Ophthalmology (AAO). He has authored peer-reviewed studies on topics ranging from corneal melt (corneal breakdown) to divergence insufficiency (outward vision problems), wearable visual field testing, and economic models of ocular disease burden. -
Vasyl Rakivnenko
AI Technical Lead, IT & Legal Design Lab, Information Systems
BioVasyl Rakivnenko is the AI Technical Lead at Stanford Law School’s Legal Design Lab, where he develops and applies AI systems to expand access to justice. A technology entrepreneur and applied AI researcher, he has led AI initiatives across startups, venture firms, and public companies.
He collaborates with Stanford faculty on research at the intersection of AI, economics, and decision-making, and has presented his work at Stanford GSB, UNLV, and more.
Vasyl holds a Bachelor’s in Business Administration from the University of Mondragon, an MBA from Kozminski University, and is a graduate of the Stanford Executive Program. -
Lindsey Ralls
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioLindsey Ralls, MD, is a Clinical Assistant Professor in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University. She is originally from California, and after undergraduate training at Stanford University she completed her medical degree and internship at Baylor College of Medicine in Houston, TX. She then returned to the Bay Area and completed her Anesthesia residency (2008) and Obstetric Anesthesia fellowship (2009) at Stanford University.
-
Nilam Ram
Professor of Communication and of Psychology
BioNilam Ram studies the dynamic interplay of psychological and media processes and how they change from moment-to-moment and across the life span.
Nilam’s research grows out of a history of studying change. After completing his undergraduate study of economics, he worked as a currency trader, frantically tracking and trying to predict the movement of world markets as they jerked up, down and sideways. Later, he moved on to the study of human movement, kinesiology, and eventually psychological processes - with a specialization in longitudinal research methodology. Generally, Nilam studies how short-term changes (e.g., processes such as learning, information processing, emotion regulation, etc.) develop across the life span, and how longitudinal study designs contribute to generation of new knowledge. Current projects include examinations of age-related change in children’s self- and emotion-regulation; patterns in minute-to-minute and day-to-day progression of adolescents’ and adults’ emotions; and change in contextual influences on well-being during old age. He is developing a variety of study paradigms that use recent developments in data science and the intensive data streams arriving from social media, mobile sensors, and smartphones to study change at multiple time scales. -
Asheen Rama
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Asheen Rama is a member of the Division of Pediatric Anesthesiology. He regularly organizes and conducts medical simulations across various hospital units, utilizing both traditional in-situ methods and advanced immersive technologies, such as virtual and augmented reality. He also collaborates with the Stanford CHARIOT program, leading efforts to integrate immersive technologies into medical education and working to scale these innovations nationally and internationally.
Dr. Rama teaches a diverse range of learners, including medical students, residents, fellows, and nurses. His academic interests focus on simulation, medical education, and artificial intelligence. Additionally, he has a strong interest in the medical humanities and has taught several Stanford undergraduate and medical student courses that explore the intersection of art and medicine. -
Sneha Ramakrishna
Assistant Professor of Pediatrics (Hematology/Oncology)
BioSneha Ramakrishna obtained her B. A. from the University of Chicago and her M.D. from the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. In medical school, through the Howard Hughes Medical Research Scholar Award, she joined Dr. Crystal Mackall’s laboratory, where she designed and developed various GD2 CAR-Ts and tested them in preclinical models. During her residency training in Pediatrics at the Children’s Hospital of Philadelphia, she cared for some of the first patients treated with CD19 CAR T cells, learning the power of this therapy first-hand. During her fellowship in Pediatric Hematology/Oncology at the Johns Hopkins/National Cancer Institute combined program, she worked with Dr. Terry Fry. She evaluated the mechanism of CD22 CAR T cell relapse in patients by developing an antigen escape model and establishing a deeper understanding of the effects of antigen density on CAR-T phenotype, expansion, and persistence (Fry…Ramakrishna…Mackall Nat Med, 2018; Ramakrishna, et al., Clinical Cancer Research, 2019). Since arriving at Stanford, Dr. Ramakrishna leads an interdisciplinary team that designs, develops, and successfully implements a robust correlative science platform for our novel CAR-T therapies. Analyzing patient samples from our first-in-human GD2 CAR-T trial (NCT04196413) treating a universally fatal cancer, diffuse midline glioma (DMG), we identified that intracerebroventricular CAR-T administration correlates with enhanced pro-inflammatory cytokines and reduced immunosuppressive cell populations in cerebrospinal fluid as compared to intravenous CAR-T administration (Majzner*, Ramakrishna*, et al., Nature 2022 *co-first authors). Her research program evaluates unique sets of patient samples using novel single-cell immune profiling to identify the drivers of CAR-T success or failure. Building on these findings, her team assesses approaches to enhance CAR-T efficacy and translate these findings to the clinic.
Clinically, Dr. Ramakrishna cares for children with solid tumors and treats hematologic, solid, and brain tumor pediatric patients with CAR T cell therapies in the Cancer Cellular Therapies program.
